UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: Results of a multicenter, randomized double-blind, controlled study

Journal of the American Academy of Dermatology, 2007-11, Vol.57 (5), p.791-799

2007

Volltextzugriff (PDF)

Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study

Journal of drugs in dermatology, 2010-01, Vol.9 (1), p.33

2010

Volltextzugriff (PDF)

Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies

Journal of drugs in dermatology, 2010-06, Vol.9 (6), p.639

2010

Volltextzugriff (PDF)

Pharmacokinetics of ingenol mebutate gel under maximum use conditions in large treatment areas

The Journal of dermatological treatment, 2018-01, Vol.29 (1), p.74-79

2018

Volltextzugriff (PDF)

Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials

Journal of drugs in dermatology, 2016-05, Vol.15 (5), p.553

2016

Volltextzugriff (PDF)

Efficacy and Safety of Subantimicrobial Dose, Modified-Release Doxycycline 40 mg Versus Doxycycline 100 mg Versus Placebo for the treatment of Inflammatory Lesions in Moderate and Severe Acne: A Randomized, Double-Blinded, Controlled Study

Journal of drugs in dermatology, 2015-06, Vol.14 (6), p.581

2015

Volltextzugriff (PDF)

Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study

Journal of drugs in dermatology, 2013-02, Vol.12 (2), p.186

2013

Volltextzugriff (PDF)

Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study

Journal of drugs in dermatology, 2014-07, Vol.13 (7), p.838

2014

Volltextzugriff (PDF)

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail

Journal of the American Academy of Dermatology, 1998-06, Vol.38 (6), p.S77-S86

1998

Volltextzugriff (PDF)

The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis

Journal of drugs in dermatology, 2014-09, Vol.13 (9), p.1124

2014

Volltextzugriff (PDF)

Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections

Clinical therapeutics, 2002-07, Vol.24 (7), p.1134-1147

2002

Volltextzugriff (PDF)

Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial

Journal of the American Academy of Dermatology, 2003-04, Vol.48 (4), p.535-541

2003

Volltextzugriff (PDF)

Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening regimen

Journal of drugs in dermatology, 2010-07, Vol.9 (7), p.805

2010

Volltextzugriff (PDF)

Fluorouracil cream 0.5% for the treatment of actinic keratoses on the face and anterior scalp: interim results of an 18-month open-label study

The Journal of clinical and aesthetic dermatology, 2008-07, Vol.1 (2), p.16-21

2008

Volltextzugriff (PDF)

Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail

Journal of the American Academy of Dermatology, 1998-06, Vol.38 (6), p.S103-S109

1998

Volltextzugriff (PDF)

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail

Journal of the American Academy of Dermatology, 1998-06, Vol.38 (6), p.S87-S94

1998

Volltextzugriff (PDF)

Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail

Journal of the American Academy of Dermatology, 1998-06, Vol.38 (6), p.S110-S116

1998

Volltextzugriff (PDF)

Fluorouracil Cream 0.5% for Actinic Keratoses on Multiple Body Sites: An 18-Month Open-Label Study

Cutis (New York, N.Y.), 2010-05, Vol.85 (5), p.267-273

2010

Volltextzugriff (PDF)

Assessment of HPA-Axis Suppression with Fluticasone Cream 0.05% in Patients with Extensive Psoriasis or Eczema

Clinical drug investigation, 1998, Vol.16 (2), p.111-116

1998

Volltextzugriff (PDF)

Clindamycin phosphate 1% gel in acne vulgaris

Advances in therapy, 2001-11, Vol.18 (6), p.244-252

2001

Volltextzugriff (PDF)

Safety of a Novel Gel Formulation of Clindamycin Phosphate 1.2%-Tretinoin 0.025% : Results From a 52-Week Open-Label Study

Cutis (New York, N.Y.), 2008-11, Vol.82 (5), p.358-366

2008

Volltextzugriff (PDF)

Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis

Cutis (New York, N.Y.), 2002-12, Vol.70 (6), p.335-339

2002

Volltextzugriff (PDF)

Platelike cutaneous osteoma

Journal of the American Academy of Dermatology, 1987-02, Vol.16 (2), p.481-484

1987

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(21)
Life Sciences & Biomedicine
(21)
Male
(21)
Science & Technology
(21)
Female
(20)
Dermatology
(19)
Adult
(18)
Middle Aged
(15)
Double-Blind Method
(14)
Treatment Outcome
(14)
Adolescent
(13)
Aged
(9)
Child
(9)
Acne Vulgaris - Drug Therapy
(8)
Biological And Medical Sciences
(8)
Drug Administration Schedule
(8)
Medical Sciences
(8)
Antifungal Agents - Administration & Dosage
(7)
Young Adult
(7)
Onychomycosis - Drug Therapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: Results of a multicenter, randomized double-blind, controlled study

Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study

Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies

Pharmacokinetics of ingenol mebutate gel under maximum use conditions in large treatment areas

Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials

Efficacy and Safety of Subantimicrobial Dose, Modified-Release Doxycycline 40 mg Versus Doxycycline 100 mg Versus Placebo for the treatment of Inflammatory Lesions in Moderate and Severe Acne: A Randomized, Double-Blinded, Controlled Study

Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study

Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail

The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis

Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections

Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial

Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening regimen

Fluorouracil cream 0.5% for the treatment of actinic keratoses on the face and anterior scalp: interim results of an 18-month open-label study

Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail

Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail

Fluorouracil Cream 0.5% for Actinic Keratoses on Multiple Body Sites: An 18-Month Open-Label Study

Assessment of HPA-Axis Suppression with Fluticasone Cream 0.05% in Patients with Extensive Psoriasis or Eczema

Clindamycin phosphate 1% gel in acne vulgaris

Safety of a Novel Gel Formulation of Clindamycin Phosphate 1.2%-Tretinoin 0.025% : Results From a 52-Week Open-Label Study

Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis

Platelike cutaneous osteoma

Suchergebnisse filtern